Global Calcium is one of the leading manufacturers and exporters of
Iron Sucrose CAS no. 8047-67-4, API, (Active Pharmaceutical Ingredient). We support the customers with exhaustive documentation. As a USDMF & EU-GMP certified global company and an established hallmark for pharmaceutical standards, Global Calcium has stood the test of time since its inception in 1979.
As manufacturer of Iron Sucrose we hereby state the following facts about the drug:
Iron Deficiency Anemia in patients with ESRD (End Stage Renal Disease): used in dialysis patients to treat Iron Deficiency Anemia with very good results.
Intravenous iron sucrose has a very high potential for reducing the burden of iron deficiency anemia because it overcomes the problems of compliance and absorption.
Iron Deficiency Anemia in pregnant women: Maternal anaemia is associated with poor intra-uterine growth and conceiving of low-birth-weight babies. This in turn could result in higher perinatal morbidity, infant mortality, developmental delays, and reduction of placental weight, volume and surface area.
There is a striking difference in the mean birth weight of the infants born of anaemic and non-anaemic mothers. Anaemia during the second trimester is associated with preterm birth. Preterm delivery is increased fivefold for iron deficiency anemia and doubled for other anaemia. Fifteen to twenty percent of maternal deaths are directly or indirectly due to anaemia and the mortality is higher if postpartum haemorrhage occurs in anaemic mothers.
Global Calcium is a leading manufacturer of this drug. We manufacture this pharmaceutical drug and make it available to domestic and overseas market